CDER Adds Gaucher Disease to 2017 Guidance Agenda Post author:Sam Post published:April 20, 2017 Post category:Drug Industry Daily CDER updated its guidance agenda for 2017, adding an item on Gaucher Disease. Source: Drug Industry Daily You Might Also Like AbbVie, Sanofi and Consegna Forge New Partnerships April 22, 2022 EMA Opens Comment on ICH-Endorsed Draft Paper on RWD/RWE July 6, 2023 Rocket Reports 100 Percent Survival in Rare Pediatric Immunodeficiency Trial May 20, 2022
